Follow the 오스코텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 오스코텍 has logged 58 insider filings. Market capitalisation: €1,174.5bn. The latest transaction was filed on 29 May 2026 (Sale). Among the most active insiders: 김정근. The full history is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,900 of 28,134 companies
66.3
score / 100
Value
39
Quality
93
FCF yld0.6%
Earn yld3.9%
EV/EBITDA23.9x
ROE·
Gross mgn98%
Net mgn52%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
OscoTech is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.